29:12

Transforming asthma care: improving patient and environmental outcomes (Promotional content from AstraZeneca)

• 17 August 2022

Sponsored

GB-38224 | August 2022

13:37

Improving patient and environmental outcomes in asthma care: Q&A session (Promotional content from AstraZeneca)

• 17 August 2022

Sponsored

GB-38229 | August 2022

11:46

Managing type 2 diabetes in primary care: update on guidelines and best practice (Promotional content from Boehringer Ingelheim for healthcare professionals only)

• 12 August 2022

Sponsored

Trajenta® (linagliptin) prescribing information and adverse event reporting

PC-GB-107166 | August 2022

05:24

Use of pregabalin during pregnancy: MHRA advice

• 8 August 2022

04:14

Miconazole oral gel to treat oral thrush in adults taking a statin

• 1 August 2022

25:19

Review of the new NICE NG28 guideline and how we can improve clinical outcomes for adults with type 2 diabetes (Promotional, product-related content developed and funded by Boehringer Ingelheim and Lilly Alliance)

• 27 July 2022

Sponsored

PC-GB-106912 | July 2022

30:32

The positive benefits of SGLT2 inhibitors in cardiovascular / renal / metabolic diseases (Promotional, product-related content developed and funded by Boehringer Ingelheim and Lilly Alliance)

• 27 July 2022

Sponsored

PC-GB-106316 | July 2022

12:50

Weight management in type 2 diabetes (Promotional, product-related content developed and funded by Boehringer Ingelheim and Lilly Alliance)

• 27 July 2022

Sponsored

PC-GB-106314 | July 2022

14:30

Type 2 diabetes and secondary cardiovascular risk (Promotional, product-related content developed and funded by Boehringer Ingelheim and Lilly Alliance)

• 27 July 2022

Sponsored

PC-GB-106311 | July 2022

10:34

Type 2 diabetes and glycaemic control (Promotional, product-related content developed and funded by Boehringer Ingelheim and Lilly Alliance)

• 27 July 2022

Sponsored

PC-GB-106310 | July 2022

19:06

Long-term value of SGLT2 inhibitors: The evidence for SGLT2 inhibitors in providing long term outcomes (Promotional, product-related content developed and funded by Boehringer Ingelheim and Lilly Alliance)

• 27 July 2022

Sponsored

PC-GB-106309 | July 2022

08:55

Evaluating the progression of renal disease in people with type 2 diabetes and CKD: the FIDELIO-DKD trial (Promotional content from Bayer plc)

• 13 July 2022

Sponsored

PP-KER-GB-0174 | July 2022

15:12

Shoulder pain

• 12 July 2022

Pro

07:43

Statins update: the nocebo effect and statin use in older adults

• 12 July 2022

Pro

19:21

The limping child: when to worry and when to refer?

• 12 July 2022

Pro

05:04

Risk of topical steroid withdrawal reactions

• 26 May 2022

05:06

Myocarditis and pericarditis following COVID-19 vaccination

• 18 May 2022

04:47

Selecting and using antihistamines during breastfeeding

• 13 May 2022

48:21

First-line practical management of cow’s milk protein allergy in a GP caseload (Sponsored by Nutricia)

• 5 May 2022

Sponsored

04:47

Guillain-Barré Syndrome following COVID-19 vaccination

• 29 April 2022

09:58

Dietary management of cow’s milk protein allergy (Promotional content from Reckitt / Mead Johnson Nutrition)

• 22 April 2022

Sponsored

RB-M-92264

04:33

Why choose to initiate Trulicity® (dulaglutide)? (Promotional content from Lilly)

• 1 April 2022

Sponsored

Trulicity® (dulaglutide) prescribing information and adverse event reporting

PP-DG-GB-1118 | April 2022

01:59

How Trulicity® (dulaglutide) 1.5 mg, 3 mg and 4.5 mg can help adults with type 2 diabetes reach their HbA1c goal (Promotional content from Lilly)

• 1 April 2022

Sponsored

Trulicity® (dulaglutide) prescribing information and adverse event reporting

PP-DG-GB-1118 | April 2022

09:13

Allergy testing (Promotional content from Reckitt / Mead Johnson Nutrition)

• 30 March 2022

Sponsored

RB-M-92263

09:52

How to take an allergy focused history (Promotional content from Reckitt / Mead Johnson Nutrition)

• 30 March 2022

Sponsored

RB-M-92261

07:30

Overview of allergy and the atopic march (Promotional content from Reckitt / Mead Johnson Nutrition)

• 30 March 2022

Sponsored

RB-M-92260

05:08

Screening for depression in primary care

• 29 March 2022

06:36

Antibody testing for COVID-19 (SARS-CoV-2 infection)

• 24 March 2022

29:54

Management of osteoporosis and the prevention of fragility fractures

• 21 March 2022

Pro

21:29

T2 Discussions: Risk assessment, screening and advice: The cornerstone to navigating adult type 2 diabetes and Ramadan (Promotional content from Boehringer Ingelheim)

• 7 March 2022

Sponsored

Trajenta® (linagliptin) prescribing information and adverse event reporting

PC-GB-106678 | March 2022

07:08

SGLT2 inhibitors in type 2 diabetes: Recommendations within updated NICE guideline NG28

• 14 February 2022

02:32

medi Soft OA Light knee brace for relief of unicompartmental osteoarthritis (Promotional content)

• 11 January 2022

Sponsored

17:11

Diagnosis, management and referral of breast pain

• 10 January 2022

Pro

20:14

Management of common physical symptoms in pregnancy

• 10 January 2022

Pro

17:30

Blurred vision

• 10 January 2022

Pro

05:45

Why is postprandial glucose so important? (Promotional content from Lilly)

• 7 January 2022

Sponsored

PP-UR-GB-0324 | January 2022

08:50

Management of acne vulgaris: NICE guideline NG198

• 7 December 2021

16:50

Getting our language right in diabetes consultations (Promotional content from Lilly)

• 3 December 2021

Sponsored

PP-BV-GB-0091 | March 2021

02:01

Masterclass TV (A promotional initiative organised and sponsored by the BMS/Pfizer Alliance)

• 23 November 2021

Sponsored

05:02

Chloramphenicol eye drops containing borax or boric acid in children under 2 years: MHRA update

• 17 November 2021

05:35

Dapagliflozin for chronic heart failure with reduced ejection fraction: NICE TA679

• 2 November 2021

07:26

Non-visible haematuria

• 27 October 2021

Pro

06:33

Pre-school wheeze

• 27 October 2021

Pro

05:28

Superficial venous thrombosis

• 27 October 2021

Pro

20:04

Addison’s disease

• 27 October 2021

Pro

07:27

Once-weekly subcutaneous semaglutide in overweight and obese adults without diabetes

• 22 October 2021

07:55

Risk of cancer: what role for non-specific markers in primary care?

• 4 October 2021

03:48

Vaginal atrophy management (Promotional content from Gedeon Richter)

• 17 August 2021

Sponsored

UK-VAG-2100013 – August 2021

5:09

Antipsychotics in people living with dementia: NICE KTT7

• 4 August 2021

03:32

Should we be screening for ovarian cancer? Results from the UKCTOCS

• 10 June 2021

11:46

Interpreting iron studies: a case-based update

• 9 June 2021

Pro

12:00

Restless legs syndrome: a case-based update

• 8 June 2021

Pro

06:58

Vitamin D supplementation and COVID-19: NICE guideline NG187

• 17 May 2021

03:12

Preventing falls: Does de-prescribing fall-risk increasing drugs make a difference?

• 14 May 2021

08:20

End-of-life recognition in primary care

• 6 April 2021

02:45

Levosert (levonorgestrel) intrauterine delivery system: licence for contraception extended

• 26 February 2021

10:32

Primary care management of post-acute COVID-19 (“long COVID”)

• 4 February 2021

08:31

Rheumatoid arthritis: a case-based update

• 11 January 2021

Pro

07:59

Frailty: a case-based update

• 10 January 2021

Pro

07:48

Acute kidney injury: a case-based update

• 9 January 2021

Pro

15:10

Psoriasis: a case-based update

• 8 January 2021

Pro

18:43

Generalised anxiety disorder and health anxiety: a case-based update

• 7 January 2021

Pro

24:47

Osteoporosis: a case-based update

• 6 January 2021

Pro

10:19

Acne vulgaris: a case-based update

• 5 January 2021

Pro

19:07

Migraine: a case-based update

• 4 January 2021

Pro

14:25

Gout: a case-based update

• 3 January 2021

Pro

05:00

Bell’s palsy: a case-based update

• 2 January 2021

Pro

6:23

Diagnosis and management of abdominal aortic aneurysm: NICE guideline NG156

• 14 December 2020

6:16

Diagnosis and management of diverticular disease: NICE guideline NG147

• 4 December 2020

5:00

Transdermal fentanyl patches for non-cancer pain: MHRA update

• 12 November 2020

1:03:43

Post-congress review: Virtual EASD Annual Meeting 2020

• 20 October 2020

7:17

Putting type 2 diabetes into remission: what are the key facts?

• 20 October 2020

7:54

Cardiovascular and renal outcomes with dapagliflozin in people with chronic kidney disease: the DAPA-CKD study

• 13 October 2020

39:50

Recognising the signs and symptoms of idiopathic pulmonary fibrosis (Promotional content from Boehringer Ingelheim)

• 8 October 2020

Sponsored

PC-GB-102994 July 2021

01:01:39

Post-congress review: ESC Congress 2020

• 6 October 2020

7:43

Venous thromboembolic diseases: NICE guideline NG158

• 23 September 2020

7:08

Direct-acting oral anticoagulants (DOACs): bleeding risk and reversal agents

• 10 September 2020

8:32

Practice-changing data from ADA 2020: a focus on GLP-1 receptor agonists in type 2 diabetes

• 4 September 2020

6:42

Prostate-specific antigen (PSA) test (Part 2): limitations and practicalities in primary care

• 28 August 2020

6:06

Safety and immunogenicity of a vaccine against SARS-CoV-2

• 20 August 2020

5:41

Prostate-specific antigen (PSA) test (Part 1): diagnosing and screening for prostate cancer

• 7 August 2020

07:13

SGLT2 inhibitors and cardiovascular outcomes in type 2 diabetes: VERTIS CV trial

• 29 July 2020

5:25

Reducing polypharmacy in elderly people with chronic conditions

• 23 July 2020

4:33

Gestational diabetes and progression to type 2 diabetes

• 17 July 2020

8:22

Ankle oedema caused by calcium channel blockers

• 14 July 2020

6:22

Musculoskeletal and rheumatic conditions: Use of corticosteroids during COVID-19

• 10 July 2020

5:56

Faecal immunochemical test (FIT) in the detection of bowel cancer

• 7 July 2020

5:11

How accurate are home blood pressure monitors?

• 2 July 2020

4:41

Raised platelets and cancer risk

• 30 June 2020

7:45

Assessment and management of tinnitus: NICE guideline NG155

• 27 June 2020

3:59

Restoring sexual and reproductive health services during COVID-19 and beyond

• 26 June 2020

5:45

Prevention of adrenal crisis during the COVID-19 pandemic

• 19 June 2020

9:51

Contraception provision when COVID-19 lockdown restrictions are eased

• 18 June 2020

7:12

SGLT inhibitors for treating type 1 diabetes: NICE technology appraisals TA597 and TA622

• 12 June 2020

4:01

COVID-19 and chronic kidney disease: NICE rapid guideline NG176

• 10 June 2020

5:05

E-cigarette use or vaping: MHRA update regarding suspected adverse reactions

• 5 June 2020

15:26

Diabetes and COVID-19 related mortality in England: an interview with Partha Kar

• 2 June 2020

1:29:33

The challenges of managing cardiometabolic chronic conditions through the current COVID-19 pandemic

• 27 May 2020

04:59

Managing heavy menstrual bleeding remotely during the COVID-19 pandemic

• 22 May 2020

9:02

Acute kidney injury: NICE guideline NG148

• 19 May 2020

2:30

Management of thyroid enlargement: NICE guideline NG145 (Part 5)

• 15 May 2020

6:23

Remote assessment of breathlessness during the COVID-19 pandemic

• 13 May 2020

3:23

Management of subclinical thyroid disease: NICE guideline NG145 (Part 4)

• 7 May 2020

03:15

Vitamin B12 replacement during the COVID-19 pandemic: British Society for Haematology guidance

• 5 May 2020

5:08

Impetigo and antimicrobial prescribing: NICE guideline NG153

• 30 April 2020

3:32

Management of thyrotoxicosis: NICE guideline NG145 (Part 3)

• 28 April 2020

4:53

Effect of reduction in dietary sodium on blood pressure

• 24 April 2020

3:06

COVID-19 management within a primary care setting

• 21 April 2020

12:18

COVID-19 and contraception

• 17 April 2020

3:43

Management of primary hypothyroidism: NICE guideline NG145 (Part 2)

• 14 April 2020

6:58

COVID-19 in people with asthma or COPD

• 9 April 2020

2:46

Assessment of thyroid disease: NICE guideline NG145 (Part 1)

• 8 April 2020

6:23

Leg ulcer infection and antimicrobial prescribing: NICE guideline NG152

• 6 April 2020

3:15

Esmya (ulipristal acetate): suspension of the licence

• 3 April 2020

2:58

COVID-19 and nonsteroidal anti-inflammatory drugs

• 2 April 2020

04:58

COVID-19 in patients with endocrine disorders

• 1 April 2020

04:16

Updates on prescribing in pregnancy: macrolide antibiotics, modafinil and valproate

• 30 March 2020

04:41

Primary hyperparathyroidism: NICE guideline NG132

• 27 March 2020

5:24

COVID-19: use of ACE inhibitors and angiotensin-receptor blockers

• 25 March 2020

5:21

Nexplanon (etonogestrel) contraceptive implants: new insertion site

• 23 March 2020

3:07

NICE guideline NG144: cannabis-based medicinal products

• 20 March 2020

2:11

Cough (acute): antimicrobial prescribing

• 18 March 2020

2:54

Hypertension in adults: diagnosis and management

• 16 March 2020

2:58

Type 2 diabetes in adults: management

• 13 March 2020

3:07

Sore throat (acute): antimicrobial prescribing

• 11 March 2020

3:13

Heavy menstrual bleeding: assessment and management

• 9 March 2020

3:11

Otitis media (acute): antimicrobial prescribing

• 6 March 2020

3:52

Menopause: diagnosis and management

• 4 March 2020